journal article·2025

A polymer-free, tumor-microenvironment responsive sol–gel platform for spatiotemporal STING activation and self-amplifying immunotherapy

Feng Feng, Wangqing Li, Qilong Li, Xuefei Sun, Zhengdong Cheng, Xiuyu Wang, Wenchao Li, Li Yao

Materials Horizons· Volume 12· Issue 22
Publisher page

Abstract

Non-nucleotide stimulators of interferon gene (STING) agonists hold promise as immunotherapeutic agents for cancer immunotherapy and postsurgical adjuvant therapy. However, as a prototypical STING agonist, DMXAA suffers from rapid degradation, off-target toxicity, and poor tumor accumulation. Here, we present a polymer-free iRGD-buSS-camptothecin-based sol capable of enhancing drug penetration, activating immune responses, and enabling therapeutic monitoring. This multifunctional sol integrates a tumor-homing cyclic peptide with reducible disulfide-linked camptothecin crosslinkers, enabling in situ sol-gel transition to achieve spatiotemporally controlled delivery of the STING agonist DMXAA into tumor parenchyma. The resulting hydrogel forms a durable drug reservoir with a >30 day tumor retention, where a single low-dose DMXAA (0.2 mg kg-1) triggers potent tumor regression, extends survival, and establishes long-term immunological memory-effectively activating systemic immune surveillance to suppress metastasis. Our strategy synergizes molecularly engineered tumor-targeting precision with spatiotemporal control of STING-driven innate immune activation, circumventing the pharmacological limitations (poor delivery and systemic toxicity) of conventional small-molecule agonists.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: interferon and immune responses · Ubiquitin and proteasome pathways · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China

Institute of Advanced Equipment, College of Energy Engineering, Zhejiang University, Hangzhou, 310027, China

College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China

The Seventh Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100010, China

Funding

National Natural Science Foundation of China

References (38)

Show source-provided references
1. Wang · Nat. Commun. · 2018 · 9 · 153210.1038/s41467-018-03915-4 ↗
2. Duan · Angew. Chem., Int. Ed. · 2019 · 58 · 67010.1002/anie.201804882 ↗
3. Liu · Nat. Commun. · 2023 · 14 · 410610.1038/s41467-023-39759-w ↗
4. Haag · Nature · 2018 · 559 · 26910.1038/s41586-018-0287-8 ↗
5. Lanng · Nat. Immunol. · 2024 · 25 · 114410.1038/s41590-024-01872-3 ↗
6. Wilson · Nat. Nanotechnol. · 2024 · 19 · 71810.1038/s41565-024-01637-x ↗
7. Shae · Nat. Nanotechnol. · 2019 · 14 · 26910.1038/s41565-018-0342-5 ↗
8. Sun · Science · 2012 · 339 · 78610.1126/science.1232458 ↗
9. Zhou · Adv. Sci. · 2025 · 12 · 241268710.1002/advs.202412687 ↗
10. Laura · Adv. Sci. · 2025 · 12 · 250029610.1002/advs.202500296 ↗
11. Liu · Chem. Eng. J. · 2023 · 475 · 14647410.1016/j.cej.2023.146474 ↗
12. Wang · J. Am. Chem. Soc. · 2024 · 146 · 2897310.1021/jacs.4c09831 ↗
13. Chen · Adv. Mater. · 2023 · 35 · 221044010.1002/adma.202210440 ↗
14. Garland · Chem. Rev. · 2022 · 122 · 597710.1021/acs.chemrev.1c00750 ↗
15. Feig · Nat. Chem. Eng. · 2025 · 2 · 20910.1038/s44286-025-00194-x ↗
16. Li · Nat. Commun. · 2025 · 16 · 162910.1038/s41467-025-56407-7 ↗
17. Gill · J. Diabetes Sci. Technol. · 2007 · 1 · 72510.1177/193229680700100517 ↗
18. Kranz · Eur. J. Pharm. Sci. · 2008 · 34 · 16410.1016/j.ejps.2008.03.004 ↗
19. Patel · J. Controlled Release · 2010 · 147 · 35010.1016/j.jconrel.2010.08.020 ↗
20. Liang · Chem. Commun. · 2011 · 47 · 123110.1039/C0CC03599H ↗
21. Liang · Adv. Mater. · 2017 · 29 · 170313510.1002/adma.201703135 ↗
22. Brendel · Angew. Chem., Int. Ed. · 2018 · 57 · 1667810.1002/anie.201808543 ↗
23. Peng · Adv. Mater. · 2024 · 36 · 231318810.1002/adma.202313188 ↗
24. Wang · Nat. Biomed. Eng. · 2020 · 4 · 109010.1038/s41551-020-0597-7 ↗
25. Li · Matter · 2024 · 7 · 344710.1016/j.matt.2024.05.041 ↗
26. Sugahara · Cancer Cell · 2009 · 16 · 51010.1016/j.ccr.2009.10.013 ↗
27. Sugahara · J. Clin. Oncol. · 2010 · 28 · e1359010.1200/jco.2010.28.15_suppl.e13590 ↗
28. Chu · Adv. Funct. Mater. · 2020 · 30 · 200591810.1002/adfm.202005918 ↗
29. Zhang · Angew. Chem., Int. Ed. · 2018 · 57 · 706610.1002/anie.201801984 ↗
30. Cao · Biomaterials · 2022 · 290 · 12185610.1016/j.biomaterials.2022.121856 ↗
31. Onyango · Nucleic Acids Res. · 2016 · 44 · 570210.1093/nar/gkw275 ↗
32. Fang · Adv. Funct. Mater. · 2025 · 35 · 242184910.1002/adfm.202421849 ↗
33. Lin · Angew. Chem., Int. Ed. · 2023 · 135 · e20231015810.1002/ange.202310158 ↗
34. Xu · J. Hematol. Oncol. · 2022 · 15 · 8710.1186/s13045-022-01307-2 ↗
35. Zheng · Adv. Mater. · 2022 · 34 · 220120010.1002/adma.202201200 ↗
36. Hao · Adv. Sci. · 2020 · 7 · 20011853
37. Lee · J. Am. Chem. Soc. · 2012 · 134 · 1266810.1021/ja303998y ↗
38. Segarra-Maset · Chem. Soc. Rev. · 2013 · 42 · 708610.1039/C2CS35436E ↗